Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy
This review of 20 RCTs and two quasi ‐RCTs (n=7711) comparing antibiotic prophylaxis (AP) with placebo/no treatment found that based on low/very low‐quality evidence, AP may reduce the risk of symptomatic UTI but not systemic UTIs, without increasing serious and minor adverse events. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 27, 2019 Category: Consumer Health News Source Type: news

Mauna Kea Nixes Deal with Cook Medical
Citing a lack of commercial progress, Mauna Kea Technologies is calling off an agreement with Cook Medical that was signed a little over three years ago involving Mauna Kea's Cellvizio platform. Paris, France-based Mauna Kea said the decision to terminate the development and distribution agreements with Cook was mutual. Cook has not officially commented on the news. Cellvizio is a multidisciplinary probe and needle-based confocal laser endoscopy platform. The device enables direct visualization of human tissues at the cellular scale and allows doctors to detect anomalies invisible with standard techniques, part...
Source: MDDI - February 21, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal
Mauna Kea (ENT:MKEA) said today that it and Cook Medical have mutually decided to terminate their development and distribution agreement. The deal, originally inked in late 2015, included the development of Mauna Kea’s Cellvizio confocal laser endomicroscopy systems for urologic applications. Paris-based Mauna Kea said that it agreed to develop a private-label version of the Cellvizio with an emphasis on characterizing upper urinary tract urothelial cancer. “Mauna Kea was understandably excited by the prospect of combining our innovative, confocal laser endomicroscopy technology with an established medical devices...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Imaging Urology Cook Medical Mauna Kea Technologies Source Type: news

Selective cystoscopy during hysterectomy reduces costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2019 Category: Drugs & Pharmacology Source Type: news

Source: - January 11, 2019 Category: General Medicine Source Type: news

FDA clears UVision360 hysteroscopy device
UVision360 said today it won FDA 510(k) clearance for its Luminelle DTx hysteroscopy system, now indicated for both hysteroscopy and cystoscopy. The Raleigh, N.C.-based company’s Luminelle DTx system is designed to allow physicians to see the internal lining of the uterus from an optimal distance to allow for the identification of suspicious tissue. The system also allows for biopsies to be performed under visualization, UVision said. “Since the best technology is typically only available in the operating room, many physicians and patients opt to skip the hysteroscopy and either perform a blind biopsy or go str...
Source: Mass Device - August 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Women's Health uvision360 Source Type: news

Triad medical center plans to start construction on $31.5 million surgery center
Wake Forest Baptist Health-Lexington Medical Center plans to start construction on its $31.5 million surgery center in September. The 26,500-square-foot surgery center will be adjacent to the outpatient surgery center at the facility. Wake Forest Baptist Medical Center announced its plans for the center in April. The new facility will have four digital operating rooms, which will accommodate various types of procedures and specialities. The center also will have a cystoscopy procedure room, a… (Source: Health Care:Biotechnology headlines)
Source: Health Care:Biotechnology headlines - June 12, 2018 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Urologists Practice Spotting Tumors With Virtual Reality Technology
BOSTON (CBS) – Virtual reality is being used in healthcare more, and a local company is using the technology to help doctors identify hard-to-see tumors in the bladder. Almost 80,000 Americans are diagnosed with bladder cancer every year. To find bladder tumors, a urologist looks directly at the inside of the bladder using a cystoscope, a small tube with a camera and light attached. Cystoscopes are equipped with technology called narrow band imaging. (WBZ-TV) Some tumors are harder to find. But to make it easier, many cystoscopes are equipped with technology called narrow band imaging (NBI). “What NBI does is it change...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 29, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall HealthWatch Local TV Virtual Reality Source Type: news

Karl Storz Focuses on Bladder Cancer Detection With New Device
Karl Storz is focusing on bladder cancer detection with its latest product. The El Segunda, CA-based company said it is launching the PDD Blue Light Flexible Video Cytoscopy System. The product launch follows the approval of a supplemental new drug application and a premarket approval supplement from FDA extending the indication for Blue Light Cystoscopy with Cysview (BLCC) to include use of the new Karl Storz PDD Blue Light Flexible Video Cystoscope. Also included in the approval is an expanded indication for the repetitive use of Cysview within the same patient and for the identification of Carcinoma in Situ (CIS); one o...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news